Preclinical Development For AAV Gene Therapy

14 May 2019
Alison McVie-Wylie, Vice President of Clinical Development at Exonics Therapeutics

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.